Cargando…

147. Non-Fermenting Gram-Negative Bloodstream Infection: A Multicenter Retrospective Cohort Study

BACKGROUND: Few data exist on clinical characteristics, therapeutic management and outcome of patients with Non-Fermenting Gram-negative bloodstream infection (NFGN-BSI). Our aim is to describe a large cohort of patients with NFGN-BSI and to investigate risk factors for 30-day mortality. Further, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pascale, Renato, Giannella, Maddalena, Corcione, Silvia, Roberto Giacobbe, Daniele, Bussini, Linda, Pancaldi, Livia, Rosselli Del Turco, Elena, Giuseppe De Rosa, Francesco, Viscoli, Claudio, Viale, Pierluigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809111/ http://dx.doi.org/10.1093/ofid/ofz360.222

Ejemplares similares

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Impact on Mortality of a Bundle for the Management of Enterococcal Bloodstream Infection
por: Bartoletti, Michele, et al.
Publicado: (2019)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study
por: Pascale, Renato, et al.
Publicado: (2021)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
por: Gatti, Milo, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
por: Gatti, Milo, et al.
Publicado: (2022)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
por: Gatti, Milo, et al.
Publicado: (2022)

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
por: Bassetti, Matteo, et al.
Publicado: (2020)

Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study
por: Bartoletti, Michele, et al.
Publicado: (2021)

Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature
por: Maccaro, Angelo, et al.
Publicado: (2021)

Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Treatment of Infections Due to MDR Gram-Negative Bacteria
por: Bassetti, Matteo, et al.
Publicado: (2019)

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)
por: Bartoletti, Michele, et al.
Publicado: (2020)

Corrigendum to: “Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)” Clinical Microbiology and Infection 26 (2020) 1545–1553
por: Bartoletti, Michele, et al.
Publicado: (2023)

Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
por: Gatti, Milo, et al.
Publicado: (2022)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic
por: Tedeschi, Sara, et al.
Publicado: (2023)

Delays in Appropriate Antibiotic Therapy for Gram-Negative Bloodstream Infections: A Multicenter, Community Hospital Study
por: Moehring, Rebekah W., et al.
Publicado: (2013)

Multicenter Surveillance of Antimicrobial Resistance among Gram-Negative Bacteria Isolated from Bloodstream Infections in Ghana
por: Donkor, Eric S., et al.
Publicado: (2023)

Multi-locus sequence typing (MLST) of non-fermentative Gram-negative bacilli isolated from bloodstream infections in southern Poland
por: Chmielarczyk, Agnieszka, et al.
Publicado: (2017)

Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy
por: Alicino, Cristiano, et al.
Publicado: (2015)

The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
por: Lu, Linli, et al.
Publicado: (2022)

The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
por: Maraolo, Alberto E., et al.
Publicado: (2021)

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
por: Viscoli, Claudio, et al.
Publicado: (2014)

Epidemiology of bloodstream infections sustained by carbapenem-resistant Klebsiella pneumonia in a large teaching hospital in northern Italy
por: Alicino, C, et al.
Publicado: (2015)

131. Duration of Therapy for the Treatment of Gram-Negative Bloodstream Infections
por: Shulder, Stephanie, et al.
Publicado: (2019)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics
por: Waters, Jessica, et al.
Publicado: (2023)

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study
por: Rinaldi, Matteo, et al.
Publicado: (2023)

How much European prescribing physicians know about invasive fungal infections management?
por: Valerio, Maricela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0udh7jisq177f1lbl0p0qib6if